Login
$NTLA
$9.97 +$0.11 (1.11%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
John M. Leonard Also a director
President and CEO
Title from the Form 4 dated Nov 2, 2026
68 Not stated Not stated $5,063,899
Edward J. Dulac III
executive vice president, chief financial officer and treasurer
51 Since 2024
2 years
Not stated $2,168,505
James Basta
executive vice president, general counsel and corporate secretary
60 Since 2021
5 years
Not stated $1,846,597
Eliana Clark
executive vice president, chief technical officer
69 Since 2022
4 years
Not stated Not reported
Michael P. Dube
vice president, chief accounting officer
48 Not stated 2023 Not reported
David Lebwohl
executive vice president, chief medical officer
71 Since 2020
6 years
Not stated $1,984,724
Birgit Schultes
executive vice president, chief scientific officer
63 Since 2025
1 year
Not stated $1,740,083
Jing L. Marantz
EVP, Chief Medical Officer
Title from the Form 4 dated Oct 26, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Frank Verwiel, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Frank Verwiel, M.D.
63 2017
9 years
Independent
Audit Committee
Bavarian Nordic A/S $232,700
John M. Leonard
68 2014
12 years
Not independent None stated IQVIA Holdings Inc. Paid as CEO
Muna Bhanji
63 2022
4 years
Independent
Audit Committee Compensation and Talent Development Committee Science and Technology Committee
Cytokinetics, Inc., Veracyte, Inc., Ardelyx, Inc. Not stated
Brian Goff
57 2024
2 years
Independent
Nominating and Corporate Governance Committee
Agios Pharmaceuticals, Inc. $196,440
Jesse Goodman, M.D., M.P.H.
74 2018
8 years
Independent None stated None stated $197,700
Fred Cohen, M.D., D.Phil.
69 2019
7 years
Independent None stated CareDx, Inc., Kyverna Therapeutics, Inc. $192,700
William Chase
58 2023
3 years
Independent
Compensation and Talent Development Committee
Parexel International Corporation, Grail, Inc. $205,200
Georgia Keresty, Ph.D., M.P.H.
64 2021
5 years
Independent None stated Solid Biosciences, Inc. $200,200

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support